Skip to content

Clinical trials

Atherosclerosis trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Finland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20082
20112
20122
20142
20181
20191
20202
20211
20223
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Unknown status5
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
University of Helsinki3
University of Turku2
Biotronik AG1
CSL Behring1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Hanna Savolainen-Peltonen1
Marjukka Kolehmainen1
Medtronic Endovascular1
NewAmsterdam Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis22
Cardiovascular Diseases4
Coronary Artery Disease3
Hypercholesterolemia3
Obesity3
Peripheral Arterial Disease3
Acute Coronary Syndrome2
Diabetes Mellitus, Type 22
Dyslipidemias2
Myocardial Infarction2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.